Lacey, WA - Unigen Pharmaceuticals, Inc., a leading research and development company of proprietary, biologically-active, plant-derived ingredients has filed suit in US District Court in Seattle, alleging that Target Corporation has violated patents that Unigen holds on products containing the ingredients scutellaria and acacia catechu that it produces on an exclusive basis for licensees in the food, drug and mass market.
The lawsuit claims that leading retail giant, Target, is selling dietary supplements that infringe on Unigen’s two patents under the Target Advanced Glucosamine and Chondroitin Complex line of products. The suit is seeking undisclosed damages and an injunction against Target from infringing on Unigen’s patents. Schiff Nutrition, maker of Move Free® Advanced, is the only authorized licensee of the patented ingredients in the food, drug and mass market, including club stores.
Unigen’s Executive Vice President and General Counsel, Thomas J. Hoolihan, commented, “Unigen spends millions of dollars on research and development and on securing patents for its proprietary ingredients. Our exclusive licensees know that we will stand behind our intellectual property and will aggressively defend our patents for ourselves and for their benefit.”
About Unigen Pharmaceuticals, Inc.
Unigen Pharmaceuticals, Inc. is a leading natural products research and development company and proprietary ingredients supplier. The Company is dedicated to the discovery of botanically-derived, therapeutic compounds that address consumer health needs and help improve quality of life.
Their research and discovery includes extensive work at both the human cell and gene level. Unigen focuses on identifying and studying the unique ingredients of medicinal botanicals and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical, functional food and pharmaceutical products.
Unigen’s Washington State office houses 80 employees, 55 of whom are scientists. Contributing to their vast library of novel botanical ingredients, the current facilities include high-throughput screening and cell culture labs, bioprospecting labs and a large-scale manufacturing facility. Unigen is part of the ECONET global family of health and natural product companies, which has operations in the United States, Canada, Korea, Mexico, Russia and China. www.unigenUSA.com
- # # # -